Clinical Research Directory
Browse clinical research sites, groups, and studies.
VR-Based Optokinetic Stimulation in Multiple Sclerosis
Sponsor: Avrasya University
Summary
The aim of this study is to investigate the acute effects of virtual reality-based optokinetic stimulation on postural sway and motion sickness symptoms in individuals with multiple sclerosis (MS)
Official title: Acute Effects of Virtual Reality-Based Optokinetic Stimulation in Individuals With Multiple Sclerosis: Does Central Vestibular Dysfunction Alter These Effects?
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-09-15
Completion Date
2025-10
Last Updated
2025-09-09
Healthy Volunteers
Yes
Conditions
Interventions
Virtual Reality-Based Optokinetic Stimulation (OKS)
A 10-minute session of virtual reality-based optokinetic stimulation (OKS) using the Oculus Quest 2 system. The stimulation speed is set at 40°/s and the direction is determined according to Fukuda test results. Postural sway and motion sickness will be assessed before and after the intervention.